Critical Illness Polyneuropathy

🩺What is Critical Illness Polyneuropathy?

The NUTRIC (Nutrition Risk in Critically Ill) score was developed by Heyland et al. and published in Critical Care Medicine in 2011. It was designed to identify critically ill patients who would benefit from aggressive protein-calorie nutrition therapy by quantifying nutrition risk. The score includes five clinical variables plus optional IL-6: age categories (<50, 50-74, ≥75 years), APACHE II score reflecting acute illness severity, SOFA score quantifying organ dysfunction, number of comorbidities (≥2 = 1 point), days from hospital admission to ICU admission (≥1 day = 1 point), and elevated IL-6 as an inflammatory marker (optional). Total score ranges 0-10 (0-9 without IL-6). A score ≥5 indicates high nutrition risk — these patients derive the greatest mortality benefit from aggressive nutrition therapy.

📊Clinical Assessment & Risk Scoring

Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Critical Illness Polyneuropathy:

• NUTRIC Score Calculator

  The NUTRIC score (Nutrition Risk in Critically Ill) is a validated ICU tool that identifies patients who will benefit most from aggressive nutrition therapy. It incorporates age, APACHE II, SOFA, comorbidities, ICU days, and IL-6.

🧬Diagnostic Logic & Scoring Breakdown

The NUTRIC score combines 5-6 clinical variables: Age <50=0, 50-74=1, ≥75=2 points. APACHE II <15=0, 15-19=1, 20-27=2, ≥28=3 points. SOFA <6=0, 6-9=1, ≥10=2 points. Comorbidities ≤1=0, ≥2=1 point. Days in ICU before admission 0=0, ≥1=1 point. IL-6 present or not available=1, absent=0. Total 0-10 (0-9 without IL-6). Score ≥5 indicates high nutrition risk.

📢Clinical Significance & Implications

The NUTRIC score is the first validated ICU nutrition risk assessment tool that specifically identifies patients who benefit from aggressive protein-calorie nutrition therapy. In the original validation study, high-risk patients (NUTRIC ≥5) who received adequate nutrition (≥80% of prescribed calories) had significantly lower 28-day mortality compared to those who received inadequate nutrition. Low-risk patients did not show a mortality benefit from aggressive nutrition. The score has been validated in multiple ICU populations and is endorsed by the Canadian Clinical Practice Guidelines for nutrition support in critically ill patients.

💡 Clinical Assessment Scenario Example

A 68-year-old male with septic shock on mechanical ventilation. APACHE II 26, SOFA 11, comorbidities: hypertension and diabetes (2), admitted from ward after 3 days. IL-6 not available. NUTRIC: age 68 (1pt) + APACHE 26 (2pt) + SOFA 11 (2pt) + comorbidities 2 (1pt) + ICU days ≥1 (1pt) + IL-6 not available (1pt) = 8/9 — high nutrition risk. Early enteral nutrition is indicated targeting ≥80% of caloric requirements.

💊Common Medications & Interventions

The following pharmacological therapies and substances are commonly referenced or adjusted based on the clinical assessment of Critical Illness Polyneuropathy:

🔗Related Diseases & Conditions

These conditions are clinically associated with Critical Illness Polyneuropathy through shared risk-scoring calculators and assessment tools:

• Refeeding Syndrome

⚠️Clinical Assessment Pitfalls

• ❌ Mistake: Counting IL-6 as absent when it is simply not measured

  ✅ Correction: If IL-6 is not available, score 1 point (same as present). Only score 0 if IL-6 is confirmed ≤400 pg/mL.

• ❌ Mistake: Using NUTRIC for all ICU patients regardless of nutrition status

  ✅ Correction: NUTRIC is specifically for nutrition risk assessment, not for general severity or mortality prediction. Use APACHE II or SOFA for prognostication.

🚑When to Seek Medical Attention

This reference supports clinical assessment of Critical Illness Polyneuropathy; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.

❓Frequently Asked Questions

📚Evidence-Based References